Tissue isoantigens A, B, and H in carcinoma of the cervix uteri: Their clinical significance
β Scribed by Saroj Gupta; Y. N. Gupta; Indra Jeet Singh; B. Sanyal; Shail Khanna; Abha Rani
- Publisher
- John Wiley and Sons
- Year
- 1981
- Tongue
- English
- Weight
- 641 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
A specific red cell adhesion test was done in 243 patients with carcinoma of the cervix uteri and showed the presence of isoantigens in only 27.16% of the patients with infiltrating squamous cell carcinoma. There was a gradual loss of isoantigens during the development of carcinoma. The test can be usefully employed in studying the evolution of the disease. The negativity of the test was found to increase as clinical severity of the disease increases. Also, the highest percentage (57.57%) of retained isoantigen was found in largeβcell nonkeratinizing carcinoma, a wellβdifferentiated type for the cervix. Followβup studies suggest that the loss of antigen indicates probable metastasis and a poor prognosis.
π SIMILAR VOLUMES
## Abstract Cervical cancer is strongly associated with infection by oncogenic forms of human papillomavirus (HPV). Although most women are able to clear an HPV infection, some develop persistent infections that may lead to cancer. The determinants of persistent infection are largely unknown. We ha
Currently, there is lack of a histologic classification of squamous cell carcinoma of the cervix that correlates significantly with patient survival. This study investigated the survival predictive value of two immunohistochemical markers, the blood group A,B,H isoantigens and the Oxford Ca antigen,
To assess the effects of radiotherapy on immune status, a wide range of assessments have been performed on patients with localized carcinoma of the cervix uteri undergoing and initially responding clinically to radical pelvic radiotherapy. Neutrophil function was essentially unchanged by treatment.
## Abstract Human papillomavirus (HPV) infection is the most important risk factor for development of cervical carcinoma. Carriers of certain HLA class II alleles, __e.g.,__ DRB1\*1501 and DQB1\*0602, are more prone to HPV 16 infection and cervical carcinoma, whereas other alleles, __e.g.,__ DRB1\*